Covalent assembly of nanoparticles as a peptidase-degradable platform for molecular MRI
Iron oxide microparticles (MPIO) are better MRI contrast agents than nanoparticles, but are of limited clinical use as they are not degradable and so risk toxicity. Here the authors present an iron oxide microparticle MRI contrast agent with peptide linkers that enable degradation into non-toxic nan...
Enregistré dans:
Auteurs principaux: | Francisco Perez-Balderas, Sander I. van Kasteren, Alaa A. A. Aljabali, Kim Wals, Sébastien Serres, Andrew Jefferson, Manuel Sarmiento Soto, Alexandre A. Khrapitchev, James R Larkin, Claire Bristow, Seung Seo Lee, Guillaume Bort, Filippo De Simone, Sandra J. Campbell, Robin P. Choudhury, Daniel C. Anthony, Nicola R. Sibson, Benjamin G. Davis |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d6193834fc8f46f68e4a4160e6d4d903 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Optimization of molecularly targeted MRI in the brain: empirical comparison of sequences and particles
par: Zarghami N, et autres
Publié: (2018) -
Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
par: Das SS, et autres
Publié: (2014) -
Urate-lowering effects of dipeptidyl peptidase-4 inhibitors
par: Taras S. Panevin, et autres
Publié: (2020) -
Multiple-component covalent organic frameworks
par: Ning Huang, et autres
Publié: (2016) -
Ubiquitin-specific peptidase 37: an important cog in the oncogenic machinery of cancerous cells
par: Ravi Chauhan, et autres
Publié: (2021)